Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan
Jhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Cancer Research Communications
|
July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan
Jhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Cancer Research Communications
|
July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Page
of 5